Pan-cancer analysis across 33 human cancer types reveals ZDHHC9 mRNA upregulation in 20 cancers, and TISIDB data indicates that ZDHHC9 negatively correlates with key immune regulators, further supporting its role in tumor progression [386]. This evidence concerns the gene ZDHHC9 and cancer.